Shenyang Xingqi Pharmaceutical Co., Ltd. logo

Shenyang Xingqi Pharmaceutical Co., Ltd. (300573)

Market Closed
10 Aug, 06:57
XSHE XSHE
¥
42. 95
+0.34
+0.7979%
¥
17.65B Market Cap
- P/E Ratio
1.4% Div Yield
12.34M Volume
- Eps
¥ 42.61
Previous Close
Add Transaction
Day Range
40.59 43.75
Year Range
35.1 59.07
Want to track 300573 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300573 closed today higher at ¥42.95, an increase of 0.7979% from yesterday's close, completing a monthly increase of 4.7306% or ¥1.94. Over the past 12 months, 300573 stock lost -40.7423%.
300573 pays dividends to its shareholders, with the most recent payment made on May 22, 2026. The next estimated payment will be in In 3 months on Nov 22, 2026 for a total of ¥1.
The last earnings report, released on May 13, 2025, exceeded the consensus estimates by 0.8325%. On average, the company has surpassed earnings expectations by 0.6025%, based on the last three reports.
Shenyang Xingqi Pharmaceutical Co., Ltd. has completed 4 stock splits, with the recent split occurring on May 22, 2026.
The company's stock is traded on one exchange.

300573 Chart

People also search for

ZTE Corporation
¥ 34.19
-0.3207%
Boe Technology Group Co., Ltd.
5.12 HKD
0%
Hithink RoyalFlush Information Network Co., Ltd.
¥ 239.59
+0.4528%
Lens Technology Co., Ltd.
¥ 34.9
+0.0287%
BOE Technology Group Co., Ltd.
¥ 5.91
+0.3396%

Shenyang Xingqi Pharmaceutical Co., Ltd. (300573) FAQ

What is the stock price today?

The current price is ¥42.95.

On which exchange is it traded?

Shenyang Xingqi Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300573.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.4%.

What is its market cap?

As of today, the market cap is 17.65B.

Has Shenyang Xingqi Pharmaceutical Co., Ltd. ever had a stock split?

Shenyang Xingqi Pharmaceutical Co., Ltd. had 4 splits and the recent split was on May 22, 2026.

Shenyang Xingqi Pharmaceutical Co., Ltd. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Ms. E. Gao CEO
XSHE Exchange
CNE100002DV1 ISIN
CN Country
2,426 Employees
22 May 2026 Last Dividend
22 May 2026 Last Split
- IPO Date

Overview

Shenyang Xingqi Pharmaceutical Co.,Ltd., established in 1977 and headquartered in Shenyang, the People's Republic of China, operates in the pharmaceutical sector with a primary focus on the research, development, production, and sale of ophthalmic medications. Its role in the pharmaceutical industry is emphasized through its engagement in the research and development of eye treatment products, alongside technology development, technical consultation, investment activities, and managing eye hospital businesses. Furthermore, the company plays a significant part in the production and wholesale distribution of pharmaceuticals in China, showcasing its integrated role in the healthcare and medical sectors within the country.

Products and Services

Shenyang Xingqi Pharmaceutical Co.,Ltd. offers a wide range of ophthalmic products catered to various eye conditions and needs:

  • Corneal Products: These are designed for treating corneal conditions, helping in the repair and regeneration of the cornea, and ensuring the overall health of the eye's outer layer.
  • Anti-bacteria: These products are aimed at combating bacterial infections in the eye, preventing the spread of infections, and maintaining ocular health.
  • Artificial Tears: Formulated to lubricate the eyes, these products provide relief for dry eyes, enhancing comfort for individuals suffering from dry eye syndrome.
  • Anti-inflammation: These medications are developed to reduce inflammation in the eyes, which can be caused by various conditions such as infections, allergies, or surgeries.
  • Anti-allergic: Specifically designed to tackle allergic reactions in the eyes, these products help in alleviating discomfort and symptoms associated with ocular allergies.
  • Mydriactics: Mydriatics are used to dilate the pupils for various diagnostic or therapeutic purposes, facilitating a wide range of ophthalmic examinations and treatments.
  • Anti-fatigue: Aimed at those experiencing eye strain and fatigue, especially common in today's digital age, these products help in rejuvenating and relieving tired eyes.
  • Dry Eye Treatment Products: Addressing the ailments of dry eye conditions, these products provide necessary moisture and relief to users, ensuring the health and comfort of the eye's surface.

In addition to its comprehensive range of ophthalmic medications, Shenyang Xingqi Pharmaceutical Co.,Ltd. is involved in technology development and technical consultation. The company also partakes in investment activities and operates eye hospital businesses, suggesting a broad scope of services that extend beyond pharmaceutical production and distribution. These engagements highlight the company's holistic approach to tackling eye health issues, underlining its commitment to advancing ocular health and wellness through a variety of channels.

Contact Information

Address: Building B, Enterprise Plaza, Shenyang, China, 110016
Phone: 86 40 0613 5599